SciELO - Scientific Electronic Library Online

 
 special issue 5The Uncertain Future of Digitization in Mexico: Can It Take Off?Covid-19 as an Accelerator of the Move towards a New Educational Model: Analyses, Challenges and Obstacles author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Economía: teoría y práctica

On-line version ISSN 2448-7481Print version ISSN 0188-3380

Abstract

GUZMAN, Alenka  and  PEREZ, Marco Antonio. Extension of the Covid-19 Pandemic Facing Access to the Vaccine and Technological and Innovative Capabilities in Mexico’s Biopharmaceutical Sector. Econ: teor. práct [online]. 2020, n.spe5, pp.69-98.  Epub July 30, 2021. ISSN 2448-7481.  https://doi.org/10.24275/etypuam/ne/e052020/guzman.

The aim of this paper is to analyze the relevance of efficient vaccine access, local absorption of technological capabilities in the bio-pharmaceutical sector and the factors fostering them, in order to contain the spread of Covid-19 and improve domestic health conditions. Having carried out pandemic extension simulations, we conclude that without adequate access of vaccines for Mexico’s entire population, the SARS-COV-2 virus, source of Covid-19, will probably remain in Mexico until mid-2022. Through the Poisson model proposed, we have found that the technological absorption and innovation capabilities of the Mexican biopharmaceutical sector (lagtime Citation -BwPatCit) are still scarce but could expand with an increase in: technological knowledge stock, team research size, academic science-technology links and cited patent value. The findings allow us to propose policies to foster bio-pharmaceutical innovation with a favorable health impact on the population.

Keywords : Covid-19 spread; vaccines; technological and innovation capabilities; Mexican bio-pharmaceutical sector.

        · abstract in Spanish     · text in Spanish